STARD13 and astrocytoma (excluding glioblastoma): However, unlike in previous studies performed on breast, lung, astrocytoma and colorectal cancers (Al Haddad et al., 2020; Basak et al., 2018; El-Sitt et al., 2012; Hanna et al., 2014a; Khalil et al., 2014; Nasrallah et al., 2014), where StarD13 was found to be necessary for cell migration, it had no effect on the 2D motility in ovarian cancer cells.